FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Minocycline Hydrochloride Extended-Release Recall

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx On…

Ascend Laboratories, LLC · Bedminster, NJ

Risk level
Class II
Reported by FDA
Jun 17, 2026
Recall ID
D-0597-2026
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Minocycline Hydrochloride Extended-Release starting Jun 1, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0597-2026 on Jun 17, 2026. Reason: Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

Product description

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30

Lot numbers, UPCs & expiration codes

Lot# 25141635, Exp 4/30/2028

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0597-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 1, 2026
FDA report date
Jun 17, 2026
Quantity
360 30-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0597-2026, exactly as published.

Show all FDA fields
City
Bedminster
State
NJ
Status
Ongoing
Country
United States
Event ID
99129
Address
135 Us Highway 202 206 Ste 15
Code information
Lot# 25141635, Exp 4/30/2028
Postal code
07921-2608
Report date
Jun 17, 2026
Product type
Drugs
Recall number
D-0597-2026
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
360 30-count bottles
Reason for recall
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Voluntary / mandated
Voluntary: Firm initiated
Product description
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 1, 2026
Initial firm notification
Letter
Center classification date
Jun 17, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0597-2026, published Jun 17, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls